Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Velocity Clinical Research- Medford, Oregon

Verified

Basic Information

Site Overview

Source: Google.

Velocity's research site in Medford was founded in 1997 as the Clinical Research Institute of Southern Oregon, and acquired by Velocity in 2017. As an independent research facility, our Medford site has long been a leading respiratory clinical research center, with a core focus on Allergy, Asthma and COPD clinical studies. The Velocity Medford team is committed to being a resource for study volunteers, to providing the highest quality of patient care with compassion and kindness and to advancing medicine through research.

Business Status

Source: Google. OPEN

Business Category

Source: Google. Research institute

Business Subcategory

Source: Google. Research institute
Source: Trial-derived.
14Total Trials
Source: Trial-derived.
0Recruiting Trials
Source: Trial-derived.
1Active Trials
Source: Trial-derived.
13Completed Trials
Source: Trial-derived.
9Unique Conditions
Source: Trial-derived.
11Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Atopic Dermatitis (6)Source: Trial-derived. Chronic Cough (2)Source: Trial-derived. Diabetes Mellitus, Type 2 (2)Source: Trial-derived. Asthma (1)Source: Trial-derived. COVID-19 (1)Source: Trial-derived. Influenza, Human (1)Source: Trial-derived. Obesity (1)Source: Trial-derived. SARS-CoV2 (1)

Sponsors

Source: Trial-derived. Incyte Corporation (3)Source: Trial-derived. Dermira, Inc. (2)Source: Trial-derived. Eli Lilly and Company (2)Source: Trial-derived. Merck Sharp & Dohme LLC (2)Source: Trial-derived. Novo Nordisk A/S (2)Source: Trial-derived. AnaptysBio, Inc. (1)Source: Trial-derived. Bond Avillion 2 Development LP (1)Source: Trial-derived. ModernaTX, Inc. (1)

Research Technology

Research technology inferred from trial participation

Source: AI-inferred. Telehealth study visits

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Continuous glucose monitoring

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. Clinical microbiology culture
Source: AI-inferred. PCR / molecular

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Ambulatory 24-hour acoustic cough monitoring
Source: AI-inferred. Electronic participant diary (eDiary) system
Source: AI-inferred. Hemagglutination inhibition (HAI) antibody assay
Source: AI-inferred. Hemagglutination inhibition (HI) serology assay
Source: AI-inferred. Home study visit (provider not specified)